Long-Term Risk of Lymphoma and Skin Cancer After Topical Calcineurin Inhibitor Use and Phototherapy in Vitiligo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Long-Term Risk of Lymphoma and Skin Cancer Was Not Increased After Topical Calcineurin Inhibitor Use and Phototherapy in a Cohort of 25,694 Patients With Vitiligo
J Am Acad Dermatol 2021 Jan 25;[EPub Ahead of Print], HJ Ju, JH Han, MS Kim, SH Lee, M Choi, KH Jeong, TY Han, CW Choi, HJ Lee, SH Oh, SH Lee, J Shin, JH Lee, SS Kim, HY Kang, SE Chang, JS Kim, DY Lee, GS Choi, DH Suh, Y Chan Kim, CJ Park, KH Kim, AY Lee, K Chan Park, MH Lee, JM BaeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.